Brief: GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement
25/02/2025 23:30
Feb 25 (Reuters) - GlycoMimetics Inc GLYC.O: GLYCOMIMETICS : ON FEB 19, RECEIVED NOTICE FROM APOLLOMICS (HONG KONG) LIMITED TERMINATING COLLABORATION AND LICENSE AGREEMENT GLYCOMIMETICS : FOLLOWING TERMINATION, CO WILL NOT HAVE ANY MATERIAL FINANCIAL OR OTHER OBLIGATIONS UNDER AGREEMENT Source text: [ID:n0001558370-25-001517] Further company coverage: GLYC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering